Eyestem Announces Completion of Phase One of its RPE Cell
India, 18 June 2025 Eyestem Research Pvt Ltd announced the completion of its phase one study for its investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE. The clinical study report of the study has been submitted to Read More